• Donal O’Connor, Clinical Manager, Health Products Regulatory Authority (HPRA)

• Greg Le Blanc, Director, Regulatory Affairs and Quality Systems, Cook Medical, Canada

Orphan and humanitarian-use medical devices

• Donal O’Connor, Clinical Manager, Health Products Regulatory Authority (HPRA)
• Tetsuya Kusakabe, Director of Office of Manufacturing Quality and Vigilance for Medical Devices, International Coordination Officer Pharmaceuticals and Medical Devices Agency (PMDA) 
• Leo Hovestadt, EU Director Governmental Affairs, Elekta
• Cho Ahram, Deputy Director, Ministry of Food and Drug Safety (MFDS), South Korea
• April Veoukas, Director Regulatory Affairs, Abbott

Paediatric medical devices 

• Kenneth Cavanaugh, Deputy Office Director, U.S Food and Drugs Administration (FDA)
  
• Joel Batts, Senior Vice President of Clinical & Regulatory Affairs, OrthoPaediatrics
• Berthold Koletzko,  Professor of Paediatrics, LMU University Hospitals

Personalized and custom medical devices

• Tracey Duffy, First Assistant Secretary, Medical Devices and Product Quality Division, TGA
• Mariana Madureira, Senior Officer, Health Products Directorate, INFARMED
• Jan Demol, Regulatory Affairs Manager, Materialise
• Matthias Neumann, Deputy Head Medical Devices Safety Unit, German Federal Ministry of Health
• Christophe Carrein, Director Quality & Compliance, Velsera

Existing pathways for innovative medical devices

• Erin Cutts, Senior International Policy Analyst, FDA
  
• Sally Prawdzik, Acting Director, Policy and International Programs, Health Canada
• Woei Jiuang Wong, Assistant Group Director of Medical Devices Cluster, Health Products Regulation Group, Health Sciences Authority (HSA)
• Joao Martins, Associate Director Regulatory Affairs Strategy, Abbott
• Yujin Lee, Chief Medical Officer, WELT Corp
• Nataliya Deych, Vice President Regulatory Affairs (EMEACLA), Edwards Lifesciences
• Helmut Scherer, Chief Technology Officer, Erbe Elektromedizin

Opportunities for convergence and reliance

• Augusto Bencke Geyer, General Manager, General Management of Health Product Technology, ANVISA
• Yasha Huang, Head of Regulatory Policy Asia Pacific, Roche Diagnostics
• Johanna Sorsa, Senior Manager Clinical and Regulatory Affairs, Siemens Healthineers
• Latifa Lakehal, Head of Standards and Regulations, Philips
• Diane Wurzburger, Executive Regulatory Affairs & Quality, Developed Markets & Global Strategic Policy, GE Healthcare

• Regulatory sandboxes
  • Paul Campbell, Innovative Devices at the Medicines and Healthcare products Regulatory Agency (MHRA)
  • Nada Alkhayat, Policy Officer, Directorate General for Health and Food Safety, European Commission
  • Koen Cobbaert, Senior Manager - Quality, Standards & Regulations, Philips
  • Bettina Möbius, Director Regulatory Affairs, Dräger
• Predetermined change controls and innovative tools in the regulatory toolbox
  • Yuang Peng, Division Director, Department of Medical Device Registration, National Medical Products Administration (NMPA)
  • Russell Pearson, AI Regulation and Policy Specialist, Innovative Devices at the Medicines and Healthcare products Regulatory Agency (MHRA)
  • Cassie Scherer, Senior Director, Digital Health Policy & Regulatory Strategy, Medtronic
  • April Veoukas, Director Regulatory Affairs, Abbott
  • Anna Hallersten, Head Regulatory Policy Europe, Roche Diagnostics